Cholesterol and Alzheimer's Disease: Clinical and Experimental Models Suggest Interactions of Different Genetic, Dietary and Environmental Risk Factors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|5|6|517-528

ISSN： 1389-4501

Source： Current Drug Targets, Vol.5, Iss.6, 2004-08, pp. : 517-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Presenilin mutations in Alzheimer's disease: molecular models suggest a potential functional locus

By Murgolo N.J.   Brown J.E.   Bayne M.L.   Strader C.D.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 11, 1996-11 ,pp. : 389-393

Elsevier

Access to resources Recommend Favorite

Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1530-1541

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer's Disease: Potential for Pharmacological Intervention

By Kivipelto M.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite

Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6007-6013

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol and Apoe: A Target for Alzheimer's Disease Therapeutics

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 553-567

Bentham Science Publishers

Access to resources Recommend Favorite